Centuple Global Ltd vs DIVI S LABORATORIES LTD

A side-by-side comparison of Centuple Global Ltd (CENTUPLE) and DIVI S LABORATORIES LTD (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads CENTUPLE vs DIVISLAB on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability22
  • Growth10
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

DIVISLAB takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

568.33
P/E ratio
93.92
0.85
P/B ratio
14.90
0.00%
Dividend yield
0.32%
₹0.06
EPS
₹96.75

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

72.98%
Return on equity
15.32%
25.93%
Return on capital
20.35%
0.40%
EBITDA margin
32.59%
0.26%
Net margin
24.32%

Growth

CENTUPLE takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

730.98%
Revenue CAGR (3Y)
10.78%
—
Profit CAGR (3Y) even
12.09%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹14 Cr
Market cap
₹2.41L Cr
₹574 Cr
Revenue
₹10,560 Cr
₹2 Cr
Net profit
₹2,568 Cr
3.26
Debt / equity
0.00
Centuple Global Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 42.0%"]
  • − ["Stock is trading at 6.92 times its book value", "Company has a high debt to equity ratio of 3.26."]
DIVI S LABORATORIES LTD
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.39 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Centuple Global Ltd full analysis DIVI S LABORATORIES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.